Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: A Patient Presents with Digital Ischemia & Gangrene

Nedal Darwish, MD, Mohamed Manaa, MD, Griffin Reyes, MD, & James G. Freeman, MD  |  Issue: June 2023  |  June 10, 2023

Click to enlarge.

Cryoglobulins, ANA, Scl-70, blood and fungal cultures were negative; complement levels were normal. His C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) had normalized.

He was admitted to our facility for possible APS and to rule out infective endocarditis in the setting of his recent dental work.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He had diminished dorsalis pedis and posterior tibial pulses, cyanotic changes in the distal tips of his toes, with blistering of toes one, two and three of his left foot. Capillary refill was extremely delayed in the affected toes, and he had ischemic changes with dark necrosis on the distal right hallux. The podiatric consultant opened the blister on the third toe, revealing clear serous fluid, which did not appear purulent. Intravenous (IV) vancomycin, IV ceftriaxone, heparin infusion, hydroxychloroquine and atorvastatin were started for limb-threatening distal ischemia in the context of his abnormal aPL profile. Blood cultures were negative, and a trans-esophageal echocardiogram was normal. The patient was discharged on warfarin, prednisone, hydroxychloroquine, nifedipine and atorvastatin.

FIGURES A–C: The patient’s left foot following first hospital discharge. FIGURE D: Digital ischemia, gangrene and cellulitis of the left foot one day prior to amputation. FIGURE E: The patient’s left foot three months post-amputation. (Click to enlarge.)

The patient was seen one week after discharge. He admitted to continued smoking, despite recommendations to quit. Prednisone tapering was started in view of the normal inflammatory markers. When seen by the podiatrist a week later, he was noted to have progressive gangrene of the left first and second toes, down to bone (see Figure 2 A–D), necessitating amputation of the first, second and third toes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Surgical pathology revealed areas of gangrenous necrosis and did not mention any signs of vasculitis. The patient was discharged on long-term antibiotics for osteomyelitis. Over the next two months, prednisone was tapered off and the other medications continued. He continued to smoke. Despite this, his digital ischemia improved and the gangrene resolved. Three months following discharge he was doing well, with no signs of recurrent disease (see Figure 2E).

An antiphospholipid panel performed exactly 12 weeks following the initial panel revealed persistent positivity of the lupus anticoagulant, with anti-cardiolipin IgM and beta-2 glycoprotein IgM levels normalizing (see Table 2).

Discussion

Digital ischemia and gangrene requiring amputation are rare and potentially lethal complications of APS. Although not included in the classification criteria for APS, dermatologic manifestations of the disorder should be recognized and appropriately evaluated. The cutaneous findings of aPL are heterogeneous, with no singular pathognomonic feature. Livedo reticularis, cutaneous ulceration and necrosis, digital gangrene and subungual splinter hemorrhages are among the dermatologic findings described in a 1,000-patient aPL cohort study by Cervera et al.3

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)arthralgiascase reportdigital ischemiagangrene

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

    February 1, 2014

    With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

    Put Hughes Syndrome on Your Radar

    April 1, 2007

    Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences